id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-1326-0003,FDA,FDA-2020-E-1326,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2020-05-26T04:00:00Z,2020,5,2020-05-26T04:00:00Z,,2020-05-26T17:52:00Z,,0,0,09000064846aee7f
FDA-2020-E-1326-0001,FDA,FDA-2020-E-1326,Letter from U S Patent and Trademark Office,Other,Letter(s),2020-04-30T04:00:00Z,2020,4,2020-04-30T04:00:00Z,,2020-04-30T16:22:18Z,,0,0,0900006484522f28
FDA-2020-E-1326-0002,FDA,FDA-2020-E-1326,"Patent Term Extension Application for SCENESSE Patent No 8,334,265",Other,Application,2020-04-30T04:00:00Z,2020,4,2020-04-30T04:00:00Z,,2020-04-30T16:23:58Z,,0,0,0900006484522f29